Longitude (Cayman) Ltd. Acadia Pharmaceuticals Inc Transaction History

Longitude (Cayman) Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$20.94 - $27.5 $649,140 - $852,500	-31,000 Reduced 40.79%	45,000 $1.09 Million
Q4 2021 Feb 03, 2022	SELL	$16.79 - $27.09 $604,440 - $975,240	-36,000 Reduced 32.14%	76,000 $1.77 Million
Q3 2021 Nov 08, 2021	SELL	$15.78 - $24.77 $1.1 Million - $1.73 Million	-70,000 Reduced 38.46%	112,000 $1.86 Million
Q2 2021 Aug 10, 2021	SELL	$19.4 - $27.42 $116,399 - $164,520	-6,000 Reduced 3.19%	182,000 $4.44 Million
Q1 2021 May 11, 2021	BUY	$25.02 - $54.99 $1.83 Million - $4.03 Million	73,300 Added 63.91%	188,000 $4.85 Million
Q4 2020 Feb 11, 2021	BUY	$41.04 - $56.79 $4.71 Million - $6.51 Million	114,700 New	114,700 $6.13 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

Stay updated on Longitude (Cayman) Ltd. with notifications on news.